Standout Papers

GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review 2024 202639
  1. GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review (2024)
    Nasreen Alfaris, Brunna Cristina Bremer Boaventura et al. EClinicalMedicine

Immediate Impact

54 standout
Sub-graph 1 of 23

Citing Papers

Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
2025 Standout
Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition?
2024 Standout
2 intermediate papers

Works of Nasreen Alfaris being referenced

Short‐ and Long‐Term Changes in Health‐Related Quality of Life with Weight Loss: Results from a Randomized Controlled Trial
2018
The utility of weight loss medications after bariatric surgery for weight regain or inadequate weight loss: A multi-center study
2016

Author Peers

Author Last Decade Papers Cites
Nasreen Alfaris 143 143 161 158 157 18 507
Luca Montesi 72 83 68 163 67 12 484
Naomi Brosnahan 87 42 151 324 167 24 507
George Thom 61 30 102 301 131 18 450
Mary Kaye Snell 90 168 143 189 32 10 532
Rachel Pryke 60 45 87 169 98 11 474
Ovidiu Galescu 52 211 70 62 27 20 478
Marcelo Papelbaum 47 224 57 60 58 23 522
Ruth Branson 33 97 83 195 193 8 493
Kwang Wei Tham 27 31 67 217 223 28 454
S. Natale 24 103 67 69 64 17 427

All Works

Loading papers...

Rankless by CCL
2026